Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dani Lakshman Yarlagadda"'
Publikováno v:
Advances in Pharmacological and Pharmaceutical Sciences, Vol 2023 (2023)
Amorphous salt solid dispersion (ASSD) of Dolutegravir amorphous salt (DSSD) was generated using quench cooling and compared to its Dolutegravir free acid solid dispersion (DFSD) to improve the solubility and bioavailability. Soluplus (SLP) was used
Externí odkaz:
https://doaj.org/article/700932ea788149498abddea0c9d64aaa
Autor:
Bheemisetty Brahmam, Farmiza Begum, Dani Lakshman Yarlagadda, Rekha Raghuveer Shenoy, Shaila Angela Lewis
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 57:547-551
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba6ea2b8ba632b555cc975b1f5d25cb
https://doi.org/10.5530/ijper.57.2.67
https://doi.org/10.5530/ijper.57.2.67
Autor:
Muralidhar Pisay, Dani Lakshman Yarlagadda, Sai Krishna Anand Vullendula, Krishnamurthy Bhat, Koteshwara Kunnatur Balasundara, Srinivas Mutalik
Publikováno v:
Pharmaceutical Development and Technology. 28:176-189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c187b17e8c6773c4e39d827be26d34d2
https://doi.org/10.1080/10837450.2023.2172039
https://doi.org/10.1080/10837450.2023.2172039
Autor:
Shailesh Perdalkar, Dani Lakshman Yarlagadda, Cannanore Ganesh Pai, Shiran Shetty, Krishnamurthy Bhat
Publikováno v:
Bioanalysis. 14:1453-1470
Inosine monophosphate dehydrogenase (IMPDH) is a crucial enzyme involved in the de novo synthesis of purine nucleotides. IMPDH activity is used to evaluate the pharmacodynamics/pharmacokinetics of immunosuppressant drugs such as mycophenolic acid and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04d2cd70b0ff22b4cfaa81209d85631b
https://doi.org/10.4155/bio-2022-0212
https://doi.org/10.4155/bio-2022-0212
Autor:
Disha Shetty, Dani Lakshman Yarlagadda, Bheemisetty Brahmam, Swapnil J. Dengale, Shaila A. Lewis
Publikováno v:
Journal of Drug Delivery Science and Technology. 84:104520
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e84fd3e3e99f44372f02eb2ebc339b0a
https://doi.org/10.1016/j.jddst.2023.104520
https://doi.org/10.1016/j.jddst.2023.104520
Autor:
Sai Krishna Anand Vullendula, Athira R. Nair, Dani Lakshman Yarlagadda, K.S. Navya Sree, Krishnamurthy Bhat, Swapnil J. Dengale
Publikováno v:
Journal of Drug Delivery Science and Technology. 78:103980
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a10fc3b2c5cc072c2b106c4e85388b7
https://doi.org/10.1016/j.jddst.2022.103980
https://doi.org/10.1016/j.jddst.2022.103980
Autor:
Sravya Uppala, Sai Krishna Anand Vullendula, Dani Lakshman Yarlagadda, Swapnil Jayant Dengale
Publikováno v:
Journal of Drug Delivery Science and Technology. 72:103431
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dde56547111509a2837573b1c88a3032
https://doi.org/10.1016/j.jddst.2022.103431
https://doi.org/10.1016/j.jddst.2022.103431
Autor:
Athira R. Nair, K.S. Navya Sree, Swapnil J. Dengale, Vullendula Sai Krishna Anand, Krishnamurthy Bhat, Dani Lakshman Yarlagadda
Publikováno v:
International journal of pharmaceutics. 602
Co-amorphous drug delivery systems are evolving as a credible alternative to amorphous solid dispersions technology. In Co-amorphous systems (CAMs), a drug is stabilized in amorphous form using small molecular weight compounds called as co-formers. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc8be5b074df3a34b34f4158dcb97cf
https://pubmed.ncbi.nlm.nih.gov/33915186
https://pubmed.ncbi.nlm.nih.gov/33915186